4-羟基雄烯二酮醋酸酯

更新时间:2024-01-02 12:19:29

4-羟基雄烯二酮醋酸酯结构式
4-羟基雄烯二酮醋酸酯结构式
品牌特惠专场
常用名 4-羟基雄烯二酮醋酸酯 英文名 4-Androsten-4-ol-3,17-dione acetate
CAS号 61630-32-8 分子量 344.44500
密度 1.18g/cm3 沸点 501.2ºC at 760 mmHg
分子式 C21H28O4 熔点 N/A
MSDS 中文版 美版 闪点 219.2ºC

 4-羟基雄烯二酮醋酸酯名称

中文名 4-羟基雄烯二酮醋酸酯
英文名 4-Androsten-4-ol-3,17-dione acetate
英文别名 更多

 4-羟基雄烯二酮醋酸酯物理化学性质

密度 1.18g/cm3
沸点 501.2ºC at 760 mmHg
分子式 C21H28O4
分子量 344.44500
闪点 219.2ºC
精确质量 344.19900
PSA 60.44000
LogP 3.97820
折射率 1.548

 4-羟基雄烯二酮醋酸酯毒性和生态

 4-羟基雄烯二酮醋酸酯安全信息

个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
危险品运输编码 NONH for all modes of transport
RTECS号 BV8153000

 4-羟基雄烯二酮醋酸酯合成线路

~97%

4-羟基雄烯二酮醋酸酯结构式

4-羟基雄烯二酮醋酸酯

61630-32-8

文献:Andrade; Paixao; De Almeida; Fernandes Roleira; Tavares Da Silva Acta Crystallographica Section C: Crystal Structure Communications, 2007 , vol. 63, # 6 p. o330-o331

~66%

4-羟基雄烯二酮醋酸酯结构式

4-羟基雄烯二酮醋酸酯

61630-32-8

文献:Marsh, David A.; Brodie, Harry J.; Garrett, Wesley; Tsai-Morris, Chon-Hwa; Brodie, Angela M. H. Journal of Medicinal Chemistry, 1985 , vol. 28, # 6 p. 788 - 795

~%

4-羟基雄烯二酮醋酸酯结构式

4-羟基雄烯二酮醋酸酯

61630-32-8

文献:Mann, John; Pietrzak, Barbara Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , # 11 p. 2681 - 2685

~%

4-羟基雄烯二酮醋酸酯结构式

4-羟基雄烯二酮醋酸酯

61630-32-8

文献:Varela, Carla; Tavares Da Silva, Elisiario J.; Amaral, Cristina; Correia Da Silva, Georgina; Baptista, Teresa; Alcaro, Stefano; Costa, Giosue; Carvalho, Rui A.; Teixeira, Natercia A. A.; Roleira, Fernanda M. F. Journal of Medicinal Chemistry, 2012 , vol. 55, # 8 p. 3992 - 4002

~%

4-羟基雄烯二酮醋酸酯结构式

4-羟基雄烯二酮醋酸酯

61630-32-8

文献:Mann, John; Pietrzak, Barbara Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983 , # 11 p. 2681 - 2685

 4-羟基雄烯二酮醋酸酯上下游产品

4-羟基雄烯二酮醋酸酯上游产品  6

4-羟基雄烯二酮醋酸酯下游产品  0

 4-羟基雄烯二酮醋酸酯文献14

更多文献
Aromatase inhibitors and the treatment of breast cancer.

J. Steroid Biochem. 24 , 91, (1986)

Inhibition of aromatase to reduce estrogen production by peripheral and ovarian tissue could be a useful approach to treating hormone-dependent breast cancer. Several C19, 17 keto steroids have been i...

Inhibition of estrogen biosynthesis and regression of mammary tumors by aromatase inhibitors.

Adv. Exp. Med. Biol. 138 , 179-90, (1981)

Overview of recent development of aromatase inhibitors.

Cancer Res. 42(8 Suppl) , 3312s-3314s, (1982)

Since the first publication in 1973 concerning aromatase inhibitors, several effective compounds have been reported by a number of investigators. Our studies with 4-hydroxyandrostene-3,17-dione, 4-ace...

 4-羟基雄烯二酮醋酸酯英文别名

[(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate